We are live on ! Find out more
GTCM

Gyon Technologies Capital Management Portfolio holdings

AUM $267M
1-Year Est. Return 11.62%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
-11.62%
3 Year Est. Return
+42.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$371M
AUM Growth
+$65.9M
Cap. Flow
+$67.5M
Cap. Flow %
18.18%
Top 10 Hldgs %
12.07%
Holding
522
New
181
Increased
107
Reduced
74
Closed
160

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$5.22M
2
TJX icon
TJX Companies
TJX
+$4.48M
3
AZN icon
AstraZeneca
AZN
+$4.01M
4
CNI icon
Canadian National Railway
CNI
+$3.93M
5
DE icon
Deere & Co
DE
+$3.88M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.51M
2
PYPL icon
PayPal
PYPL
+$3.48M
3
AYI icon
Acuity Brands
AYI
+$3.39M
4
PFE icon
Pfizer
PFE
+$3.35M
5
META icon
Meta Platforms (Facebook)
META
+$2.98M

Sector Composition

Rank Sector Weight
1 Financials 23.31%
2 Technology 18.47%
3 Healthcare 15.14%
4 Industrials 12.83%
5 Consumer Discretionary 12.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTG icon
51
MGIC Investment
MTG
$6.35B
$2.11M 0.57%
141,176
+14,474
+11% +$210K
BPMC
52
DELISTED
Blueprint Medicines
BPMC
$2.11M 0.57%
+20,495
New +$1.91M
WCC
53
WESCO International
WCC
$18.2B
$2.1M 0.57%
+18,213
New +$2.01M
CYTK icon
54
Cytokinetics
CYTK
$10.7B
$2.06M 0.56%
57,748
+6,764
+13% +$199K
ASO icon
55
Academy Sports + Outdoors
ASO
$3.02B
$2.06M 0.55%
+51,442
New +$2.05M
MCFE
56
DELISTED
McAfee Corp. Class A Common Stock
MCFE
$2.03M 0.55%
+91,912
New +$2.38M
MRK icon
57
Merck
MRK
$316B
$2.03M 0.55%
26,983
-2,237
-8% -$170K
SPY icon
58
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$2.03M 0.55%
4,722
+395
+9% +$174K
XLP icon
59
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$2M 0.54%
29,023
+107
+0.4% +$7.63K
TWLO icon
60
Twilio
TWLO
$29.5B
$1.97M 0.53%
6,184
+4,966
+408% +$1.81M
TVTX icon
61
Travere Therapeutics
TVTX
$5.21B
$1.95M 0.52%
+80,275
New +$1.47M
VRNS icon
62
Varonis Systems
VRNS
$4.98B
$1.94M 0.52%
31,828
+25,904
+437% +$1.62M
CLDX icon
63
Celldex Therapeutics
CLDX
$3.07B
$1.93M 0.52%
+35,764
New +$1.68M
OPTU
64
Optimum Communications Inc
OPTU
$343M
$1.92M 0.52%
+92,526
New +$2.7M
FE icon
65
FirstEnergy
FE
$27.9B
$1.91M 0.52%
53,712
+30,265
+129% +$1.15M
LPRO
66
DELISTED
Open Lending Corp
LPRO
$1.89M 0.51%
+52,466
New +$2.01M
WRB icon
67
W.R. Berkley
WRB
$26.5B
$1.87M 0.5%
+57,409
New +$1.89M
PRG icon
68
PROG Holdings
PRG
$1.83B
$1.83M 0.49%
43,621
+7,146
+20% +$321K
ABBV icon
69
AbbVie
ABBV
$431B
$1.83M 0.49%
+16,951
New +$1.94M
PFGC icon
70
Performance Food Group
PFGC
$17.7B
$1.78M 0.48%
38,394
+29,098
+313% +$1.34M
MDT icon
71
Medtronic
MDT
$110B
$1.78M 0.48%
14,179
-8,973
-39% -$1.16M
SNDX icon
72
Syndax Pharmaceuticals
SNDX
$1.69B
$1.76M 0.48%
+92,385
New +$1.54M
CRTO icon
73
Criteo S.A. Ordinary Shares
CRTO
$1.13B
$1.73M 0.47%
+47,174
New +$1.81M
HSY icon
74
Hershey
HSY
$36B
$1.71M 0.46%
10,089
+2,211
+28% +$391K
ALLE icon
75
Allegion
ALLE
$14.1B
$1.69M 0.45%
12,769
+5,720
+81% +$795K
1 2
3
4 5

Similar funds

CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
ACMV
August Capital Management VII Palo Alto, California $265M AUM 26.86% 1-Year Est. Return
SCM
Stormborn Capital Management Greenwich, Connecticut $263M AUM 8.83% 1-Year Est. Return
RW
Reframe Wealth Fairfax, Virginia $260M AUM
A
Accenture Dublin, Ireland $254M AUM 59.98% 1-Year Est. Return
CAN
Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return
JW
Jenkins Wealth Englewood, Colorado $249M AUM
APP
Alpha Paradigm Partners Chicago, Illinois $242M AUM 9.65% 1-Year Est. Return

Gyon Technologies Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Gyon Technologies Capital Management held 522 positions worth $371M, up 22% from $305M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Gyon Technologies Capital Management deployed $67.5M of net new capital in Q3 2021, opening 181 new positions and adding to 107 existing holdings. Its largest new stake was AstraZeneca: 34,466 shares worth $4.14M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $3.35M trimmed.

  • Gyon Technologies Capital Management's largest Q3 2021 buy was AstraZeneca: 34,466 shares worth $4.14M.
  • Gyon Technologies Capital Management added most to Microsoft in Q3 2021, an estimated $5.22M increase.
  • Gyon Technologies Capital Management's biggest Q3 2021 reduction was Pfizer, cutting an estimated $3.35M.
  • Gyon Technologies Capital Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $3.51M.
  • Gyon Technologies Capital Management's ten largest holdings make up 12% of its $371M portfolio in Q3 2021.
  • Gyon Technologies Capital Management opened 181 new positions and closed 160 in Q3 2021.
  • Gyon Technologies Capital Management's portfolio value rose 22% quarter-over-quarter to $371M.

Based on Gyon Technologies Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.